Download this Q&A to learn more.
Lonza recently announced a significant capacity expansion at its Stein, Switzerland, drug product facility. This Q&A paper provides more information about the added capabilities, how they complement its existing drug product network, and the benefits the expansion will bring for biopharmaceutical and biotech companies.
Offered Free by: Lonza
See All Resources from: Lonza
